Literature DB >> 16546466

Potential of diffusion tensor MRI in the assessment of periventricular leukomalacia.

G G Fan1, B Yu, S M Quan, B H Sun, Q Y Guo.   

Abstract

AIM: To investigate magnetic resonance (MR) diffusion tensor imaging (DTI) and fibre tractography in the assessment of altered major white matter (WM) fibre tracts in periventricular leukomalacia (PVL).
MATERIALS AND METHODS: Twelve children (male:female = 7:5, age range 3-10 years; mean age = 6.5 years) who had suffered PVL were included in this study. Meanwhile, Twelve age-matched normal controls (male:female = 6:6, age range 4-12 years; mean age = 7.3 years) with normal MRI findings and no neurological abnormalities were recruited for comparison. DTI was performed with 15 different diffusion gradient directions and DTI colour maps were created from fractional anisotropy (FA) values and the three vector elements. To identify alteration of WM fibre tracts in patient of PVL quantitatively, FA values on diffusion tensor colour maps were compared between the patients and controls. Quantitative analysis was performed using the regions of interest (ROI) method settled on the central part of all identifiable WM fibres, including the corticospinal tract (CST) in the brainstem, middle cerebellar peduncle (MCP), medial lemniscus (ML), anterior/posterior limb of internal capsule (ICAL/ICPL), arcuate fasciculus (AF), posterior thalamic radiation (PTR), genu of corpus callosum (GCC), splenium of corpus callosum (SCC), corona radiata (CR), cingulum (CG), and superior longitudinal fasciculus (SLF). The averaged FA value of each WM fibre was measured and summarized as the mean +/- standard deviation (SD). All data were analysed by paired Student's t-test. A p-value of less than 0.05 was considered to indicate statistical significance.
RESULTS: Visual investigation of WM fibre tracts showed that the ICAL, brainstem CST, ML, MCP, and external capsule (EC) was similar in controls and subjects. However, the ICPL, AF, PTR, CR, CG, SLF and corpus callosum, were all attenuated in size. All 12 cases of PVL showed a significant mean FA reduction in the ICPL, AF, PTR, CR, CG, SLF, SCC, and GCC in comparison with the ipsilateral regions of healthy controls (p<0.05). However, there were no statistically significant differences of the ICAL, ML, MCP, and brainstem CST when analysed using a two-tailed Student's t-test for paired data (p>0.01).
CONCLUSION: DTI can provide more information for understanding the pathophysiology of motor disability and associated sensory handicap in PVL.

Entities:  

Mesh:

Year:  2006        PMID: 16546466     DOI: 10.1016/j.crad.2006.01.001

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  12 in total

1.  Quantitative analysis of brain pathology based on MRI and brain atlases--applications for cerebral palsy.

Authors:  Andreia V Faria; Alexander Hoon; Elaine Stashinko; Xin Li; Hangyi Jiang; Ameneh Mashayekh; Kazi Akhter; John Hsu; Kenichi Oishi; Jiangyang Zhang; Michael I Miller; Peter C M van Zijl; Susumu Mori
Journal:  Neuroimage       Date:  2010-11-05       Impact factor: 6.556

2.  Anisotropy of transcallosal motor fibres indicates functional impairment in children with periventricular leukomalacia.

Authors:  Inga Koerte; Paula Pelavin; Berit Kirmess; Teresa Fuchs; Steffen Berweck; Ruediger P Laubender; Ingo Borggraefe; Sebastian Schroeder; Adrian Danek; Claudia Rummeny; Maximilian Reiser; Marek Kubicki; Martha E Shenton; Birgit Ertl-Wagner; Florian Heinen
Journal:  Dev Med Child Neurol       Date:  2010-12-01       Impact factor: 5.449

3.  Diffusion tensor imaging-demonstrated differences between hemiplegic and diplegic cerebral palsy with symmetric periventricular leukomalacia.

Authors:  H K Cho; S H Jang; E Lee; S Y Kim; S Kim; Y H Kwon; S M Son
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-13       Impact factor: 3.825

4.  Corpus callosum alterations in very preterm infants: perinatal correlates and 2 year neurodevelopmental outcomes.

Authors:  Deanne K Thompson; Terrie E Inder; Nathan Faggian; Simon K Warfield; Peter J Anderson; Lex W Doyle; Gary F Egan
Journal:  Neuroimage       Date:  2011-12-01       Impact factor: 6.556

5.  Assessment of cortical visual impairment in infants with periventricular leukomalacia: a pilot event-related FMRI study.

Authors:  Bing Yu; Qiyong Guo; Guoguang Fan; Na Liu
Journal:  Korean J Radiol       Date:  2011-07-22       Impact factor: 3.500

6.  Comparing quantitative tractography metrics of motor and sensory pathways in children with periventricular leukomalacia and different levels of gross motor function.

Authors:  Dong-wook Rha; Won Hyuk Chang; Jinna Kim; Eun Geol Sim; Eun Sook Park
Journal:  Neuroradiology       Date:  2011-12-16       Impact factor: 2.804

7.  Hypoxic injury during neonatal development in murine brain: correlation between in vivo DTI findings and behavioral assessment.

Authors:  Halima Chahboune; Laura R Ment; William B Stewart; Douglas L Rothman; Flora M Vaccarino; Fahmeed Hyder; Michael L Schwartz
Journal:  Cereb Cortex       Date:  2009-04-20       Impact factor: 5.357

8.  Diffusion tensor imaging in children with periventricular leukomalacia: variability of injuries to white matter tracts.

Authors:  L M Nagae; A H Hoon; E Stashinko; D Lin; W Zhang; E Levey; S Wakana; H Jiang; C C Leite; L T Lucato; P C M van Zijl; M V Johnston; S Mori
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

9.  Intrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits.

Authors:  Fadoua Saadani-Makki; Sujatha Kannan; Malek Makki; Otto Muzik; James Janisse; Roberto Romero; Diane Chugani
Journal:  J Child Neurol       Date:  2009-09       Impact factor: 1.987

10.  Spatial patterns of whole brain grey and white matter injury in patients with occult spastic diplegic cerebral palsy.

Authors:  Xuetao Mu; Binbin Nie; Hong Wang; Shaofeng Duan; Zan Zhang; Guanghui Dai; Qiaozhi Ma; Baoci Shan; Lin Ma
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.